
Overview
Global Pharma Cm is a contract manufacturer of dietary supplements and medical products, offering production in various forms such as softgels, tablets, syrups, and sprays. The company collaborates with partners from Poland and abroad, adhering to ISO 22000 and ISO 13485 standards. Their services include personalized product development and support throughout the production process, from ingredient selection to final documentation.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $704,394 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 60 days late). 5 of 6 audited by a statutory auditor.
- 202512/06/2026
- 202427/06/2025
- 202302/07/2024
- 202226/05/2023
- 202113/09/2022
- 202002/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Liquid supplements
- Spray supplements
- Soft capsules
- Hard capsules
- Tablets
- Lozenges
- Syrups
- Shots
Websites
The site is available in: Polish and English.
- globalpharma.plProdukcja kontraktowa suplementów diety – Global Pharma CMWordPress 3.15Google Tag ManagerYoast SEOPPolylangLLiteSpeed
Authorized Representatives
Manner of representation
In the event of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company and to represent the company, provided that the President of the Management Board and the Vice-President of the Management Board are authorized to make declarations of will on behalf of the company independently and to represent the company independently.
Supervisory board
Ownership
| Owner |
|---|
Neuca S.A. |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-05-16.
19 1160 2202 0000 0005 5170 0281
29 1160 2202 0000 0005 5400 0456
88 1160 2202 0000 0005 5190 9529
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $60,545$60,545 |
Buildings and premises | $3.1M$3,130,347 |
Public aid
12 public aid cases recorded, with a total value of $647,783.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 16, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Icvc Certyfikacja sp. z o.o. | |
| Mar 18, 2022 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Banku Gospodarstwa Krajowego | |
| Oct 29, 2021 | Regional investment aid | –– | Prezes Banku Gospodarstwa Krajowego |
European Funds
4 projects co-financed from European Funds recorded, with total EU co-financing of $457,278.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-01-01 | Implementation of innovative technology for the production of dietary supplements at GLOBAL PHARMA CM SP. Z O. O. | $214.8K$214,847 | Operational Programme Smart Growth | |
| 2020-10-01 | Promotion of the Global Pharma Contract Manufacturing product brand in international markets in 2021-2022. | $33,912$33,912 | Operational Programme Smart Growth | |
| 2019-04-15 | Promotion of the Global Pharma product brand on international markets in 2019-2020 | $79,125$79,125 | Operational Programme Smart Growth |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Prosuplement Group sp. z o.o. | $34,819,545.29 | prosuplement.com | ||
| Curtis Health Caps S.A. | $34,513,094.78 | chc.com.pl | ||
| Efferta Pharma sp. z o.o. | $33,051,786.19 | efferta.pl | ||
| Exim Pharma sp. z o.o. | $24,694,130.27 | eximpharma.eu | ||
| Master Pharm S.A. | $23,116,954.19 | masterpharm.pl | ||
| Symbiofarm Krok sp. k. | $16,922,181.13 | symbiofarm.pl | ||
| Europharma Alliance sp. z o.o. | $15,439,864.68 | pharmaalliance.eu | ||
| Ośrodek Badawczo-Produkcyjny Politechniki Łódzkiej Ichem sp. z o.o. | $10,474,927.81 | ichem.com.pl | ||
| Stella Nutrition sp. z o.o. | $5,376,276.72 | stellagroup.pl | ||
| Tantus sp. z o.o. | $5,274,248.80 | tantus.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-24 | Switch to PKD 2025 (6 PKD 2007 codes → 10 PKD 2025 codes) | |
| 2022-11-21 | PKD change (Added: 64.92.Z) | |
| 2022-04-14 | Share capital increase (100,000.00 PLN → 110,000.00 PLN) | |
| 2021-03-05 | Entered in the register |
FAQ
Last updated: 2026-10-19